| Metric | FY2027 Range | Speaker |
|---|---|---|
| Total Revenue | $7.0B – $7.2B (organic contraction 2%–4%) | CFO |
| Adjusted EBITDA | $705M – $715M (margin 9.9%–10.1%) | CFO |
| Adjusted Diluted EPS | $9.50 – $9.70 | CFO |
| Free Cash Flow | At least $600M | CFO |
| Metric | Value | Speaker/Context |
|---|---|---|
| Q4 FY2026 Revenue | $1.75B | CFO, organic contraction ~6% |
| FY2026 Revenue | $7.26B | CFO, organic decline ~3% |
| Q4 Adjusted EBITDA | $181M (10.3% margin) | CFO |
| FY2026 Adjusted EBITDA Margin | 9.7% | CFO |
| Q4 Adjusted Diluted EPS | $2.62 | CFO |
| FY2026 Adjusted Diluted EPS | $10.75 | CFO |
| Q4 Free Cash Flow | $336M | CFO |
| FY2026 Free Cash Flow | $577M | CFO |
| FY2027 Recompete Loss Headwind | ~$400M | CFO |
| FY2027 Large Wins Ramp (assumed) | $500M | CFO, vs. potential run rate >$800M |
| FY2028 Expected Free Cash Flow (ex-benefit) | At least $530M (~$13/share) | CFO |